← Back
$IOVA All transactions

IOVANCE BIOTHERAPEUTICS, INC.

M

$ Value

$0

Shares

41,668

Price

$0

Filed

Jun 4

Insider

Name

Vogt Frederick G

Title

Interim CEO & General Counsel

CIK

0001719678

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-02

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

291,682

Footnotes

Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. | Represents common stock remaining after deducting the common stock withheld for taxes. | Each RSU represents a contingent right to receive one share of the Issuer's common stock. | The remaining RSUs will vest in equal quarterly installments. | Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. | Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Filing Info

Accession No.

0001104659-25-056440

Form Type

4

Issuer CIK

0001425205

Vogt Frederick G's History

Date Ticker Type Value
2026-03-05 IOVA M $0
2026-03-05 IOVA F $123K
2026-03-05 IOVA M $0
2026-03-02 IOVA M $0
2026-03-02 IOVA F $86K
2026-03-02 IOVA M $0
2026-03-02 IOVA M $0
2025-12-02 IOVA M $0
2025-12-02 IOVA F $9K
2025-12-02 IOVA M $0

Other Insiders at IOVA (90d)

Insider Bought Sold Last
BILINSKY IGOR
Chief Operating Officer
2026-03-05
Vogt Frederick G
Interim CEO & General Counsel
2026-03-05
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
2026-03-05
Puri Raj K.
Chief Regulatory Officer
2026-03-05
Kirby Daniel Gordon
Chief Commercial Officer
2026-02-24